Harvard Bioscience Inc. (HBIO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Harvard Bioscience Inc.

    NASDAQ: HBIO · Real-Time Price · USD
    0.49
    -0.03 (-5.81%)
    At close: Aug 29, 2025, 3:58 PM

    Harvard Bioscience Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 94.14M 112.25M 113.33M 118.9M
    Cost of Revenue
    		 39.37M 46.18M 52.52M 51.25M
    Gross Profit
    		 54.77M 66.07M 60.82M 67.65M
    Operating Income
    		 -6.21M 1.89M -6.93M 2.07M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -11.66M -2.56M -9.18M -140K
    Net Income
    		 -12.4M -3.42M -9.52M -288K
    Selling & General & Admin
    		 43.7M 46.89M 49.53M 48.95M
    Research & Development
    		 10.41M 11.76M 12.33M 10.8M
    Other Expenses
    		 6.87M 5.53M 6.12M 5.84M
    Operating Expenses
    		 60.98M 64.18M 67.98M 65.59M
    Interest Expense
    		 3.21M 3.59M 2.55M 1.54M
    Selling & Marketing Expenses
    		 22.21M 24.11M 25.04M 24.64M
    Cost & Expenses
    		 100.35M 110.36M 120.5M 116.84M
    Income Tax Expense
    		 740K 859K 337K 148K
    Shares Outstanding (Basic)
    		 43.54M 42.42M 41.41M 40.34M
    Shares Outstanding (Diluted)
    		 43.54M 42.42M 41.41M 40.34M
    EPS (Basic)
    		 -0.28 -0.08 -0.23 -0.01
    EPS (Diluted)
    		 -0.28 -0.08 -0.23 -0.01
    EBITDA
    		 -1.47M 8.03M 944K 11.31M
    EBIT
    		 -8.46M 1.03M -6.63M 1.4M
    Depreciation & Amortization
    		 6.98M 7M 7.58M 7.62M

    Add to Watchlist